143 related articles for article (PubMed ID: 31256160)
1. Endoscopic Evaluation of Neoadjuvant Chemotherapeutic Efficacy in Gastric Cancer before Gastrectomy Might be as Useful as Histological Assessment after Gastrectomy.
Sugawara N; Ota K; Terazawa T; Tanaka R; Akutagawa H; Yamaguchi T; Imai Y; Harada S; Kojima Y; Tashiro K; Kii T; Lee SW; Kawai M; Egashira Y; Goto M; Uchiyama K; Hirose Y; Takeuchi T; Higuchi K
Digestion; 2020; 101(4):466-472. PubMed ID: 31256160
[TBL] [Abstract][Full Text] [Related]
2. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.
Sasaki K; Onodera S; Otsuka K; Satomura H; Kurayama E; Kubo T; Takahashi M; Ito J; Nakajima M; Yamaguchi S; Miyachi K; Kato H
Med Oncol; 2017 Aug; 34(8):139. PubMed ID: 28707042
[TBL] [Abstract][Full Text] [Related]
3. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
4. Pathological response measured using virtual microscopic slides for gastric cancer patients who underwent neoadjuvant chemotherapy.
Kawai S; Shimoda T; Nakajima T; Terashima M; Omae K; Machida N; Yasui H
World J Gastroenterol; 2019 Sep; 25(35):5334-5343. PubMed ID: 31558877
[TBL] [Abstract][Full Text] [Related]
5. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.
Hu SB; Liu CH; Wang X; Dong YW; Zhao L; Liu HF; Cao Y; Zhong DR; Liu W; Li YL; Gao WS; Bai CM; Shang ZH; Li XY
World J Surg Oncol; 2019 Jan; 17(1):3. PubMed ID: 30606195
[TBL] [Abstract][Full Text] [Related]
6. Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).
Kurokawa Y; Shibata T; Sasako M; Sano T; Tsuburaya A; Iwasaki Y; Fukuda H
Gastric Cancer; 2014; 17(3):514-21. PubMed ID: 23999869
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.
Kosaka T; Akiyama H; Miyamoto H; Sato S; Tanaka Y; Sato K; Kunisaki C; Endo I
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1047-1055. PubMed ID: 30911769
[TBL] [Abstract][Full Text] [Related]
8. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
Picado O; Dygert L; Macedo FI; Franceschi D; Sleeman D; Livingstone AS; Merchant N; Yakoub D
J Surg Res; 2018 Dec; 232():422-429. PubMed ID: 30463751
[TBL] [Abstract][Full Text] [Related]
9. A case report of advanced gastric small cell carcinoma with neoadjuvant chemotherapy followed by radical total gastrectomy.
Wang B; Jiao N; Shi L
Asian J Surg; 2020 Dec; 43(12):1205-1206. PubMed ID: 33069575
[No Abstract] [Full Text] [Related]
10. Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis.
Heger U; Bader F; Lordick F; Burian M; Langer R; Dobritz M; Blank S; Bruckner T; Becker K; Herrmann K; Siewert JR; Ott K
Gastric Cancer; 2014; 17(3):478-88. PubMed ID: 23996162
[TBL] [Abstract][Full Text] [Related]
11. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
12.
Schneider PM; Eshmuminov D; Rordorf T; Vetter D; Veit-Haibach P; Weber A; Bauerfeind P; Samaras P; Lehmann K
BMC Cancer; 2018 May; 18(1):548. PubMed ID: 29743108
[TBL] [Abstract][Full Text] [Related]
13. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.
Migita K; Nashimoto A; Yabusaki H; Matsuki A; Aizawa M
Int J Clin Oncol; 2016 Feb; 21(1):102-9. PubMed ID: 26017926
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
17. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study.
Yoshikawa T; Tanabe K; Nishikawa K; Ito Y; Matsui T; Kimura Y; Hasegawa S; Aoyama T; Hayashi T; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S385-9. PubMed ID: 24595801
[TBL] [Abstract][Full Text] [Related]
18. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Neoadjuvant Chemoradiation on Anastomotic Leak and Additional 30-Day Morbidity and Mortality in Patients Undergoing Total Gastrectomy for Gastric Cancer.
Haskins IN; Kroh MD; Amdur RL; Ponksy JL; Rodriguez JH; Vaziri K
J Gastrointest Surg; 2017 Oct; 21(10):1577-1583. PubMed ID: 28744744
[TBL] [Abstract][Full Text] [Related]
20. Blast from the past: Perioperative use of the Maruyama computer program for prediction of lymph node involvement in the surgical treatment of gastric cancer following neoadjuvant chemotherapy.
Rawicz-Pruszyński K; Mielko J; Ciseł B; Skórzewska M; Pikuła A; Gęca K; Skoczylas T; Kubiatowski T; Kurylcio A; Polkowski WP
Eur J Surg Oncol; 2019 Oct; 45(10):1957-1963. PubMed ID: 31178298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
